Instituto de Diagnóstico S.A. (SNSE:INDISA)
Chile · Delayed Price · Currency is CLP 2,699.00
-1.00 (-0.04%)
At close: Jun 10, 2026
Instituto de Diagnóstico Income Statement
Financials in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 280,844 | 272,306 | 239,071 | 218,934 | 191,288 | 188,543 | |
Revenue Growth (YoY) | 14.41% | 13.90% | 9.20% | 14.45% | 1.46% | 35.30% |
Cost of Revenue | 207,737 | 201,626 | 180,958 | 174,046 | 145,783 | 137,858 |
Gross Profit | 73,107 | 70,680 | 58,113 | 44,887 | 45,505 | 50,686 |
Selling, General & Admin | 54,180 | 53,074 | 39,311 | 36,277 | 28,729 | 24,165 |
Other Operating Expenses | -22,169 | -22,421 | 696.88 | 403.63 | -361.94 | 80.75 |
Operating Expenses | 36,813 | 35,684 | 44,155 | 41,092 | 32,194 | 28,316 |
Operating Income | 36,293 | 34,996 | 13,958 | 3,796 | 13,312 | 22,369 |
Interest Expense | -7,328 | -7,446 | -7,617 | -8,606 | -4,747 | -2,620 |
Interest & Investment Income | 531.22 | 531.22 | 835.42 | 1,175 | 728.93 | 89.39 |
Earnings From Equity Investments | -15,735 | -13,902 | 1,007 | 841.18 | 3,064 | 4,660 |
Currency Exchange Gain (Loss) | 477.99 | 1,433 | 10.71 | -0.94 | 65.01 | 14.47 |
Other Non Operating Income (Expenses) | -136.05 | -144.83 | -203.13 | 213.86 | 229.69 | -136.42 |
EBT Excluding Unusual Items | 14,104 | 15,467 | 7,992 | -2,581 | 12,652 | 24,378 |
Pretax Income | 14,104 | 15,467 | 7,992 | -2,581 | 12,652 | 24,378 |
Income Tax Expense | 194.1 | -192.5 | 715.61 | -2,725 | -397.51 | 3,728 |
Net Income | 13,910 | 15,660 | 7,276 | 144.31 | 13,050 | 20,650 |
Net Income to Common | 13,910 | 15,660 | 7,276 | 144.31 | 13,050 | 20,650 |
Net Income Growth | 60.43% | 115.23% | 4942.01% | -98.89% | -36.80% | 489.81% |
Shares Outstanding (Basic) | 147 | 144 | 141 | 141 | 141 | 141 |
Shares Outstanding (Diluted) | 147 | 144 | 141 | 141 | 141 | 141 |
Shares Change (YoY) | 4.18% | 1.96% | - | - | - | - |
EPS (Basic) | 94.74 | 108.98 | 51.63 | 1.02 | 92.60 | 146.53 |
EPS (Diluted) | 94.74 | 108.98 | 51.63 | 1.02 | 92.60 | 146.53 |
EPS Growth | 53.99% | 111.09% | 4942.01% | -98.89% | -36.80% | 489.81% |
Free Cash Flow | 15,388 | 21,931 | 17,254 | 12,083 | 872.55 | -16,615 |
Free Cash Flow Per Share | 104.81 | 152.62 | 122.43 | 85.74 | 6.19 | -117.90 |
Dividend Per Share | - | - | 15.500 | 0.310 | 27.800 | 73.200 |
Dividend Growth | - | - | 4900.00% | -98.89% | -62.02% | 490.32% |
Gross Margin | 26.03% | 25.96% | 24.31% | 20.50% | 23.79% | 26.88% |
Operating Margin | 12.92% | 12.85% | 5.84% | 1.73% | 6.96% | 11.86% |
Profit Margin | 4.95% | 5.75% | 3.04% | 0.07% | 6.82% | 10.95% |
Free Cash Flow Margin | 5.48% | 8.05% | 7.22% | 5.52% | 0.46% | -8.81% |
EBITDA | 44,861 | 43,493 | 22,598 | 12,463 | 20,425 | 23,421 |
EBITDA Margin | 15.97% | 15.97% | 9.45% | 5.69% | 10.68% | 12.42% |
D&A For EBITDA | 8,567 | 8,498 | 8,640 | 8,667 | 7,114 | 1,052 |
EBIT | 36,293 | 34,996 | 13,958 | 3,796 | 13,312 | 22,369 |
EBIT Margin | 12.92% | 12.85% | 5.84% | 1.73% | 6.96% | 11.86% |
Effective Tax Rate | 1.38% | - | 8.96% | - | - | 15.29% |
Advertising Expenses | - | 1,381 | 1,597 | 1,913 | 1,078 | 535.25 |